Xtant Medical Reports Strong Q1 2025 Results with Elevated Revenue Guidance Xtant Medical Holdings, Inc. showcases a robust performance in Q1 2025, with revenue growth and increased guidance promising a bright future for the company.

Xtant Medical Reports Strong Q1 2025 Results with Elevated Revenue Guidance #United_States #Belgrade #Q1_2025 #Xtant_Medical #Trivium_Allograft